{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:13:40Z","timestamp":1787242420434,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.sapharm.2025.10.009","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:56:19Z","timestamp":1761724579000},"page":"292-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A multisite pilot type 2 hybrid implementation-effectiveness trial of a community pharmacist-led model of collaborative care for Medication Assisted Treatment for Opioid Dependence: outcomes of the EPIC-MATOD trial"],"prefix":"10.1016","volume":"22","author":[{"given":"Suzanne","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Grist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosco","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Dostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pene","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-6778","authenticated-orcid":false,"given":"Ali","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.sapharm.2025.10.009_bib1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","volume":"24","author":"Ma","year":"2019","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.sapharm.2025.10.009_bib2","series-title":"Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, cost-effectiveness and Implementation Guidelines","author":"Mattick","year":"2009"},{"key":"10.1016\/j.sapharm.2025.10.009_bib3","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"bmj"},{"key":"10.1016\/j.sapharm.2025.10.009_bib4","series-title":"Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV\/AIDS Prevention","year":"2004"},{"issue":"5","key":"10.1016\/j.sapharm.2025.10.009_bib5","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.sapharm.2025.10.009_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108464","article-title":"Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001\u20132018: implications for treatment systems and potential impact on client outcomes","volume":"219","author":"Jones","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1071\/PY18099","article-title":"Patient access to opioid substitution treatment pharmacy and medical service providers in South Australia: geospatial mapping","volume":"25","author":"Le","year":"2019","journal-title":"Aust J Prim Health"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/14659891.2018.1523968","article-title":"\u201cA lot of people call it liquid handcuffs\u201d\u2013barriers and enablers to opioid replacement therapy in a rural area","volume":"24","author":"Wood","year":"2019","journal-title":"J Subst Use"},{"key":"10.1016\/j.sapharm.2025.10.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2023.104939","article-title":"Measuring the importance of different barriers to opioid agonist treatment using best-worst scaling in an Australian setting","volume":"138","author":"Hall","year":"2023","journal-title":"Health Policy"},{"key":"10.1016\/j.sapharm.2025.10.009_bib10","series-title":"National Opioid Pharmacotherapy Statistics Annual Data Collection 2022","year":"2022"},{"key":"10.1016\/j.sapharm.2025.10.009_bib11","series-title":"Victorian Overdose Deaths, 2013\u20132022","year":"2023"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/add.14784","article-title":"Recent trends in heroin and pharmaceutical opioid\u2010related harms in Victoria, Australia up to 2018","volume":"115","author":"Lam","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2025.10.009_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.sapharm.2025.10.009_bib14","first-page":"1097","article-title":"Pharmacist-prescriber collaborative models of care for opioid use disorder: an overview of recent research","volume":"10","author":"Cheetham","year":"2024","journal-title":"Curr Opin Psychiatr"},{"issue":"1","key":"10.1016\/j.sapharm.2025.10.009_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Sci Clin Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.japh.2019.10.014","article-title":"Pharmacists on the front-line of solving a public health crisis: increasing access to medications for opioid use disorder","volume":"60","author":"Luli","year":"2020","journal-title":"J Am Pharmaceut Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib17","first-page":"478","article-title":"Pharmacists and the opioid crisis: a narrative review of pharmacists' practice roles","volume":"3","author":"Bratberg","year":"2020","journal-title":"JACCP: J Am Coll Clin Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2025.10.009_bib18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/jac5.1331","article-title":"Mobilizing pharmacists to address the opioid crisis: a joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy. JACCP","volume":"3","author":"Coon","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2025.10.009_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4066\/AMJ.2011.706","article-title":"Provision of opioid substitution therapy services in Australian pharmacies","volume":"4","author":"Chaar","year":"2011","journal-title":"Australas Med J"},{"issue":"11","key":"10.1016\/j.sapharm.2025.10.009_bib20","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1360-0443.2007.02016.x","article-title":"Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005","volume":"102","author":"Sheridan","year":"2007","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.sapharm.2025.10.009_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.sapharm.2022.09.009","article-title":"Informing a collaborative-care model for delivering medication assisted treatment for opioid dependence (MATOD): an analysis of pharmacist, prescriber and patient perceptions","volume":"19","author":"Cheetham","year":"2023","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2025.10.009_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.sapharm.2017.02.017","article-title":"Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: patient and pharmacist views","volume":"14","author":"Le","year":"2018","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2025.10.009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"8","key":"10.1016\/j.sapharm.2025.10.009_bib24","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1016\/j.sapharm.2021.11.007","article-title":"A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for medication assisted treatment for opioid dependence: protocol for the EPIC-MATOD study","volume":"18","author":"Nielsen","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.10.009_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2025.10.009_bib26","article-title":"Standards for reporting implementation studies (StaRI) statement","volume":"356","author":"Pinnock","year":"2017","journal-title":"bmj"},{"issue":"1","key":"10.1016\/j.sapharm.2025.10.009_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2025.10.009_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11469-018-9936-2","article-title":"A narrative review of pharmacotherapy treatment for opioid addiction and application in a community-based model in Victoria, Australia","volume":"18","author":"Vishwanath","year":"2020","journal-title":"Int J Ment Health Addiction"},{"issue":"6","key":"10.1016\/j.sapharm.2025.10.009_bib29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/dar.12979","article-title":"The lived experience of Australian opioid replacement therapy recipients in a community\u2010based program in regional Victoria","volume":"38","author":"Patil","year":"2019","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"10.1016\/j.sapharm.2025.10.009_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/ijgi12050180","article-title":"Gis analysis of adequate accessibility to public transportation in metropolitan areas","volume":"12","author":"Alamri","year":"2023","journal-title":"ISPRS Int J GeoInf"},{"key":"10.1016\/j.sapharm.2025.10.009_bib31","series-title":"Socio-Economic Indexes for Areas (SEIFA)","year":"2016"},{"key":"10.1016\/j.sapharm.2025.10.009_bib32","unstructured":"NDARC Technical Report: Trends in the Use of Opioid Agonist Treatment in Victoria, 2013-2022. Sydney: UNSW2023."},{"key":"10.1016\/j.sapharm.2025.10.009_bib33","series-title":"Policy for Maintenance Pharmacotherapy for Opioid Dependence","year":"2016"},{"issue":"9","key":"10.1016\/j.sapharm.2025.10.009_bib34","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Publ Health"},{"issue":"5","key":"10.1016\/j.sapharm.2025.10.009_bib35","article-title":"Retention of patients in opioid substitution treatment: a systematic review","volume":"15","author":"O'Connor","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.sapharm.2025.10.009_bib36","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/add.15514","article-title":"The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15\u2010year retrospective cohort study","volume":"116","author":"Bharat","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.sapharm.2025.10.009_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/dar.12083","article-title":"Validation and implementation of the Australian treatment outcomes profile in specialist drug and alcohol settings","volume":"33","author":"Ryan","year":"2014","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.sapharm.2025.10.009_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2011.11.035","article-title":"The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF","volume":"15","author":"da Rocha","year":"2012","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.sapharm.2025.10.009_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/16066350009005590","article-title":"Assessing client satisfaction with treatment for substance use problems and the development of the Treatment Perceptions Questionnaire (TPQ)","volume":"8","author":"Marsden","year":"2000","journal-title":"Addict Res"},{"issue":"4","key":"10.1016\/j.sapharm.2025.10.009_bib40","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/1468-0262.00442","article-title":"Efficient estimation of average treatment effects using the estimated propensity score","volume":"71","author":"Hirano","year":"2003","journal-title":"Econometrica"},{"issue":"4","key":"10.1016\/j.sapharm.2025.10.009_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40273-023-01243-0","article-title":"The use of a discrete choice experiment including both duration and dead for the development of an EQ-5D-5L value set for Australia","volume":"41","author":"Norman","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.sapharm.2025.10.009_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40273-017-0585-2","article-title":"Estimating the reference incremental cost-effectiveness ratio for the Australian health system","volume":"36","author":"Edney","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.sapharm.2025.10.009_bib43","article-title":"Pharmacy-based care model for the treatment of opioid use disorder: pilot findings and novel care adaptations during COVID-19\"(MM11)","author":"Green","year":"2020","journal-title":"Addiction Sci Clin Pract"},{"issue":"10","key":"10.1016\/j.sapharm.2025.10.009_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ajhp\/zxaa060","article-title":"A physician-pharmacist collaborative care model to prevent opioid misuse","volume":"77","author":"Lagisetty","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2025.10.009_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.9740\/mhc.n183353","article-title":"Clinical psychiatric pharmacist involvement in an outpatient buprenorphine program","volume":"3","author":"Grgas","year":"2013","journal-title":"Mental Health Clin"},{"issue":"4","key":"10.1016\/j.sapharm.2025.10.009_bib46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jac5.1768","article-title":"Pharmacist\u2010delivered comprehensive medication management in a substance use disorder clinic, an 18\u2010month descriptive study","volume":"6","author":"Tran","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.10.009_bib47","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.sapharm.2020.08.021","article-title":"Impact of the COVID-19 pandemic on pharmacist-administered vaccination services","volume":"17","author":"Patel","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2025.10.009_bib48","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1016\/j.sapharm.2021.08.013","article-title":"Pharmacy practice in emergency response during the COVID-19 pandemic: lessons from Australia","volume":"18","author":"Parajuli","year":"2022","journal-title":"Res Soc Adm Pharm"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125004772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125004772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:51:06Z","timestamp":1773924666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125004772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1551741125004772"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.10.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multisite pilot type 2 hybrid implementation-effectiveness trial of a community pharmacist-led model of collaborative care for Medication Assisted Treatment for Opioid Dependence: outcomes of the EPIC-MATOD trial","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}